← Leaderboards
Thomas W Mittag
Mount Sinai School Of Medicine Of Nyu
$3,871,776
Attributed
$3,871,776
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $423.8K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$3,871,776 · 3
By mechanism
R01$3,871,776 · 3
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Oscar A Candia$7,854,421
- Randall Griepp$6,718,072
- Douglas Thomas Dieterich$1,765,604
Others in their field
Top investigators on “Glaucoma”
- Rohit Varma · University Of Southern California$58,233,961
- Janey L Wiggs · Massachusetts Eye And Ear Infirmary$36,083,461
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$27,740,623
- Linda M Zangwill · University Of California San Diego$23,025,291
- Robert N Weinreb · University Of California, San Diego$21,784,031
Research focus
GlaucomaRetinal GanglionFluorescent Dye /ProbeApoptosisLaboratory RatImmunofluorescence TechniqueIschemiaMitochondrial Disease /DisorderBiomarkerProtein BindingLaboratory MouseConfocal Scanning MicroscopyIntraocular PressureBiological Signal TransductionEye Disorder ChemotherapyEnzyme InhibitorsNeuroprotectantsImage ProcessingAromataseFlow CytometryAntioxidantsCalcium Channel BlockersElectroretinographyDrug Receptors
Grant awards (10)
Retinal ganglion cell loss in aging mice.$411,475
R01 · FY2007 · EY · contact PI
Retinal ganglion cell loss in aging mice.$413,792
R01 · FY2006 · EY · contact PI
Retinal ganglion cell loss in aging mice.$423,750
R01 · FY2005 · EY
Retinal ganglion cell loss in aging mice.$423,750
R01 · FY2004 · EY
Death signals in the glaucomatous retina.$381,375
R01 · FY2004 · EY
Death signals in the glaucomatous retina.$381,375
R01 · FY2003 · EY
Death signals in the glaucomatous retina.$381,375
R01 · FY2002 · EY
Death signals in the glaucomatous retina.$381,375
R01 · FY2001 · EY
NEUROPROTECTIVE DRUGS IN GLAUCOMA$339,975
R01 · FY2001 · EY
NEUROPROTECTIVE DRUGS IN GLAUCOMA$333,534
R01 · FY2000 · EY